Bryant David  Lim net worth and biography

Bryant Lim Biography and Net Worth

Bryant D. Lim joined Idera in September of 2018 as General Counsel and Secretary of the Board of Directors.  Prior to joining Idera, Mr. Lim served as Vice President, Assistant General Counsel of Incyte Corporation. Prior to Incyte, Mr. Lim held roles of increasing responsibility at ViroPharma Incorporated, Merck & Co., Inc. and Morgan, Lewis & Bockius, LLP.nbsp; Mr. Lim began his legal career as a law clerk for a federal judge.
Mr. Lim received his J.D. from Villanova University School of Law, where he serves on its adjunct faculty. Mr. Lim received his Bachelor of Arts from University of Rochester.

What is Bryant David Lim's net worth?

The estimated net worth of Bryant David Lim is at least $0.00 as of March 25th, 2021. Mr. Lim owns 30,434 shares of Idera Pharmaceuticals stock worth more than $0 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Lim may own. Additionally, Mr. Lim receives an annual salary of $480,960.00 as SVP at Idera Pharmaceuticals. Learn More about Bryant David Lim's net worth.

How old is Bryant David Lim?

Mr. Lim is currently 51 years old. There are 8 older executives and no younger executives at Idera Pharmaceuticals. Learn More on Bryant David Lim's age.

What is Bryant David Lim's salary?

As the SVP of Idera Pharmaceuticals, Inc., Mr. Lim earns $480,960.00 per year. Learn More on Bryant David Lim's salary.

How do I contact Bryant David Lim?

The corporate mailing address for Mr. Lim and other Idera Pharmaceuticals executives is 505 EAGLEVIEW BLVD. SUITE 212, EXTON PA, 19341. Idera Pharmaceuticals can also be reached via phone at (484) 348-1600 and via email at [email protected]. Learn More on Bryant David Lim's contact information.

Has Bryant David Lim been buying or selling shares of Idera Pharmaceuticals?

Bryant David Lim has not been actively trading shares of Idera Pharmaceuticals over the course of the past ninety days. Most recently, Bryant David Lim sold 7,630 shares of the business's stock in a transaction on Thursday, March 25th. The shares were sold at an average price of $1.36, for a transaction totalling $10,376.80. Following the completion of the sale, the senior vice president now directly owns 30,434 shares of the company's stock, valued at $41,390.24. Learn More on Bryant David Lim's trading history.

Who are Idera Pharmaceuticals' active insiders?

Idera Pharmaceuticals' insider roster includes John Kirby (CFO), Bryant Lim (SVP), Daniel Soland (COO), and Elizabeth Tarka (Insider). Learn More on Idera Pharmaceuticals' active insiders.

Bryant David Lim Insider Trading History at Idera Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/25/2021Sell7,630$1.36$10,376.8030,434View SEC Filing Icon  
1/12/2021Sell1,711$4.21$7,203.31View SEC Filing Icon  
1/5/2021Sell1,465$3.91$5,728.15View SEC Filing Icon  
1/7/2020Sell1,603$1.78$2,853.34View SEC Filing Icon  
12/21/2018Buy4,000$3.05$12,200.004,743View SEC Filing Icon  
See Full Table

Bryant David Lim Buying and Selling Activity at Idera Pharmaceuticals

This chart shows Bryant David Lim's buying and selling at Idera Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Idera Pharmaceuticals Company Overview

Idera Pharmaceuticals logo
Aceragen, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.50
Low: $0.17
High: $7.23

2 Week Range

Now: N/A

Volume

21,870 shs

Average Volume

464,030 shs

Market Capitalization

$450.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25